Structural Analysis of the Simultaneous Activation and Inhibition of γ-Secretase Activity in the Development of Drugs for Alzheimer's Disease
<b>Significance:</b> The majority of the drugs which target membrane-embedded protease γ-secretase show an unusual biphasic activation-inhibition dose-response in cells, model animals, and humans. Semagacestat and avagacestat are two biphasic drugs that can facilitate cognitive decline i...
Saved in:
Main Authors: | Željko M. Svedružić (Author), Katarina Vrbnjak (Author), Manuel Martinović (Author), Vedran Miletić (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease
by: Miguel A. Maia, et al.
Published: (2019) -
A multiparametric approach to monitor the effects of γ-secretase inhibition along the whole intestinal tract
by: Laure Droy-Dupré, et al.
Published: (2012) -
Effects of the γ-secretase inhibitor semagacestat on hippocampal neuronal network oscillation
by: Mihaly eHajos, et al.
Published: (2013) -
Adipocyte-specific blockade of gamma-secretase, but not inhibition of Notch activity, reduces adipose insulin sensitivity
by: David P. Sparling, et al.
Published: (2016) -
Evaluation of Selected Plant Phenolics via Beta-Secretase-1 Inhibition, Molecular Docking, and Gene Expression Related to Alzheimer's Disease
by: Tugba Uçar Akyürek, et al.
Published: (2024)